## RKLB: Rocket Lab Corporation - XLI: Industrials

### Executive Summary

PARABOLIC warning: MRS_20 at 12.4% exceeds exhaustion threshold (10.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($44.48)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_20 drops below exhaustion threshold

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. RKLB DEADLINE: ROSEN, A LEADING FIRM, Encourages Rocket Lab USA, Inc. Investors to Secure Counsel Before Important April 28 Deadline in Securities Class Action - RKLB**
- Source: FOX40 News | 20251207T170907 | Neutral | Relevance: 99%
- Rosen Law Firm is encouraging investors of Rocket Lab USA, Inc. (NASDAQ:RKLB) to secure legal counsel before the April 28, 2025 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Rocket Lab made false and misleading statements between November 12, 2024, and February 25, 2025, regarding significant delays in barge landing tests, a critical water problem, and the true launch timeline and contract reliability of its Neutron rocket. Investors who purchased RKLB securities during this period may be entitled to compensation.

**2. Saintil Merline, Rocket Lab director, sells $480k in RKLB stock**
- Source: Investing.com | 20251206T044355 | Neutral | Relevance: 99%
- Saintil Merline, a director at Rocket Lab Corp (NASDAQ:RKLB), sold 10,000 shares of common stock valued at $480,000 on December 4, 2025. This transaction comes as Rocket Lab announced record quarterly revenue of approximately $155 million for Q3 2025, achieved a 100% mission success rate with 18 Electron launches, and is preparing for further missions. Analyst firms Cantor Fitzgerald and Needham have reiterated Overweight and Buy ratings, respectively, on RKLB stock.

**3. Rocket Lab USA (RKLB) Stock Jumps 5% as SpaceX $800 Billion Valuation Fuels Sector Excitement**
- Source: CoinCentral | 20251209T110902 | Bullish | Relevance: 98%
-  Rocket Lab USA's (RKLB) stock surged over 5% following news of SpaceX's target $800 billion valuation, invigorating the commercial space sector. The company's Neutron rocket fairing has completed testing and is slated for its first launch in 2026. Analysts are bullish on RKLB, with some setting price targets as high as $83, as the stock has already climbed over 100% year-to-date.

**4. RKLB stock bounces back from 27% crash as Wall Street eyes 2026 comeback, here's why targets hit $65+**
- Source: Red94 | 20251208T140907 | Bullish | Relevance: 98%
-  Rocket Lab stock (RKLB) has rebounded from a 27% crash, with Wall Street analysts raising price targets to over $65 due to a transformative 2026 outlook. Despite recent volatility and a delay in the Neutron rocket's first launch, the company's strong Q3 2025 earnings, record revenue, and a substantial $1.1 billion backlog are fueling bullish sentiment. Analysts view the recent selloff as fear-driven rather than fundamental, expecting significant growth and potential unlocking of the medium-lift market if the Neutron rocket succeeds in its planned Q1 2026 launch.

**5. Rocket Lab Awarded R&D Funding from Canadian Space Agency**
- Source: GlobeNewswire | 20251209T130903 | Bullish | Relevance: 98%
- Rocket Lab has been awarded $999,951 CAD in funding from the Canadian Space Agency (CSA) to develop a new medium-class reaction wheel. This technology, designed for 500kg-1,000kg satellites, will be developed and qualified at Rocket Lab's Toronto facility, aiming to strengthen Canada's space technology supply chain and expand Rocket Lab's satellite component portfolio.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Needham | $63 | $63 | 0% |
| 2025-11-19 | B of A Securiti | $60 | $50 | +20% |
| 2025-11-12 | Morgan Stanley | $67 | $68 | -1% |
| 2025-11-12 | Needham | $63 | $55 | +15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Needham | reit | Buy |
| 2025-11-19 | B of A Securiti | main | Buy |
| 2025-11-12 | Morgan Stanley | main | Equal-Weight |
| 2025-11-12 | Needham | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($2.04M) |
| Sells | 19 ($26.16M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 29.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 7.8% (+5.4%)
- Blackrock Inc.: 5.9% (+38.0%)
- Capital World Invest: 2.7% (+9.4%)
- State Street Corpora: 2.3% (+13.6%)
- BAILLIE GIFFORD & CO: 2.3% (+176.1%)

### Key Risks

1. High beta (2.21) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $26M sold (19 transactions in 90 days).
3. Elevated short interest (9.7%): bears positioning against stock.
4. Near-term weakness: 5.2% below SMA50 despite long-term uptrend.

### Catalysts

- Analyst target momentum: 3 raises (avg +17%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +22.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.45 suggests fair value with growth premium. Balance sheet: strong liquidity (3.2x). Revenue growth strong at 47% YoY. Analyst sentiment positive (3 raises, avg +17%). Insider selling cluster ($26.2M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.5B |
| Beta | 2.21 |
| 52W Range | $14.71 - $73.97 |
| Short Interest | 9.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.45 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from -10.3% to 12.4% (+22.7% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (12.4% > 10.0%), caution on chasing. MRS_5 at 8.8% confirms short-term momentum alignment. AM_20 at 14.6% shows strong absolute momentum above own 20MA. Outperforming sector by 13.1pp, stock-specific strength. MACD histogram positive (1.45), confirming momentum. RSI neutral at 57.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 12.43% (CS: 97) | Strong |
| RSI_14 | 56.7 | Neutral |
| MACD Histogram | 1.45 | Bullish |
| vs SMA20 | 1.146x | Above |
| vs SMA50 | 0.948x | Below |
| vs SMA200 | 1.367x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $51.56
- **Stop Loss:** $44.48 (13.7% risk)
- **Target:** $58.64 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 70
- **Position Value:** $3,609.20
- **Portfolio %:** 3.61%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-26 (Est: $-0.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.10 | $-0.03 | +71.3% |
| 2025Q2 | $-0.11 | $-0.13 | -17.9% |
| 2025Q1 | $-0.12 | $-0.12 | +0.5% |
| 2024Q4 | $-0.10 | $-0.10 | -2.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*